Missing Data in Noninferiority Trials

Statistics in Biopharmaceutical Research

Volumn 5, Issue 4, 2013, Pages 383-393

  Wiens, Brian L ^a   Rosenkranz, Gerd K ^b  

^a ALCON RESEARCH LTD   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Clinical trials; Intent to treat; Missing at random

Indexed keywords

ANALYTICAL ERROR; ARTICLE; CLINICAL PROTOCOL; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); DATA ANALYSIS; HUMAN; INFORMATION PROCESSING; NONINFERIORITY TRIAL; PRACTICE GUIDELINE; SAMPLING ERROR; SENSITIVITY ANALYSIS; SIMULATION; STATISTICAL ANALYSIS; STUDY DESIGN;

EID: 84889684743     PISSN: None     EISSN: 19466315     Source Type: Journal    
DOI: 10.1080/19466315.2013.847383     Document Type: Article

References (20)

1. Blackwelder, W. C. 1982. 'Proving the Null Hypothesis' in Clinical Trials. Controlled Clinical Trials, 3: 345 - 353.
2. Fleming, T. R. 2008. Current Issues in Non-inferirority Trials. Statistics in Medicine, 27: 317 - 332.
3. Food and Drug Administration. March 2010. Guidance for Industry: Noninferiority Clinical Trials Rockville, Maryland: Food and Drug Administration.
4. Gallo, P. and Chuang-Stein, C. 2009. A Note on Missing Data in Noninferiority Trials. Drug Information Journal, 43: 469 - 474.
5. Hung, H. M. J., Wang, S.-J., Tsong, Y., Lawrence, J. and O'Neil, R. T. 2003. Some Fundamental Issues With Noninferiority Testing in Active Controlled Trials. Statistics in Medicine, 22: 213 - 225.
6. International Conference on Harmonisation. 1998. Statistical Principles for Clinical Trials, E-9 Geneva, Switzerland: International Conference on Harmonisation.
7. International Conference on Harmonisation. 2000. Choice of Control Group and Related Issues in Clinical Trials, E-10 Geneva, Switzerland: International Conference on Harmonisation.
8. Kenward, M. G. and Molenberghs, G. 2009. Last Observation Carried Forward: A Crystal Ball?. Journal of Biopharmaceutical Statistics, 19: 872 - 888.
9. Little, R. J. A. and Rubin, D. B. 2002. Statistical Analysis With Missing Data (2nd ed.), Hoboken, NJ: Wiley.
10. Mallinckrodt, C. H., Clark, W. S. and David, S. 2001. Accounting for Dropout Bias Using Mixed-Effects Models. Journal of Biopharmaceutical Statistics, 11: 9 - 21.
11. Molenberghs, G. and Kenward, M. G. 2007. Missing Data in Clinical Trials, Chichester, UK: Wiley.
12. Panel on Handling Missing Data in Clinical Trials. 2010. The Prevention and Treatment of Missing Data in Clinical Trials, Washington, DC: The National Academies Press.
13. Piaggio, G., Elbourne, D. R., Altman, D. G., Pocock, S. J. and Evans, S. J. W. 2006. Reporting of Noninferiority and Equivalence Randomized Trials. An Extension of the CONSORT Statement. Journal of the American Medical Association, 295: 1152 - 1160.
14. Robins, J. M., Rotnitzky, A. and Zhao, L. P. 1995. Analysis of Semiparametric Regression Models for Repeated Outcomes in the Presence of Missing Data. Journal of the American Statistical Asssociation, 90: 106 - 121.
15. Rothmann, M. D., Wiens, B. L. and Chan, I. S. F. 2011. Design and Analysis of Noninferiority Trials, Boca Raton, FL: Chapman & Hall/CRC.
16. Rubin, D. B. 1976. Inference and Missing Data. Biometrika, 63: 581 - 592.
17. Wiens, B. L. 2002. Choosing an Equivalence Limit for Noninferiority or Equivalence Studies. Controlled Clinical Trials, 23: 2 - 14.
18. Wiens, B. L. and Zhao, W. 2007. The Role of Intention to Treat in Analysis of Noninferiority Studies. Clinical Trials, 4: 286 - 291.
19. Yan, X., Lee, S. and Li, N. 2009. Missing Data Handling Methods in Medical Device Clinical Trials. Journal of Biopharmaceutical Statistics, 19: 1085 - 1098.
20. Yoo, B. 2010. Impact of Missing Data on Type 1 Error Rates in NonInferiority Trials. Pharmaceutical Statistics, 9: 87 - 99.